Status:
UNKNOWN
Description of the Safety and Functionality of a Rectoscope (P201630551)
Lead Sponsor:
Instituto de Investigación Hospital Universitario La Paz
Conditions:
Oncological Rectal Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Most patients with rectal cancer receive neoadjuvant therapy. This usually causes a decrease in tumor size. In approximately 20% of patients who receive neoadjuvant therapy, the tumor disappears compl...
Eligibility Criteria
Inclusion
- Men and women over 18 years old.
- Patients with rectal cancer (15 cm or less from the anal margin), whether or not they have received neoadjuvant treatment, in whom cancer surgery is to be performed through the anterior (abdominal) route, whether laparoscopic or not.
- Patients who accept their participation in this study, after explaining the study details.
- Patients who sign the informed consent.
Exclusion
- Patients who are going to undergo an abdominoperineal amputation or transanal surgery for rectal cancer.
- Patients who do not accept their participation in this study.
Key Trial Info
Start Date :
July 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04899726
Start Date
July 14 2020
End Date
September 1 2022
Last Update
May 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario La Paz
Madrid, Spain, 28046